C
Cytokinetics, Incorporated (CYTK)
62.50
0.00 (0.00%)
Get all premium features to the best stock analysis tool
62.50
0.00 (0.00%)
This stock has a consensus price target of $87.00 based on the ratings of 23 analysts. The high is $136.00 and the low is $56.00.
| Target | Lowest Price Target | Consensus Price Target | Highest Price Target |
|---|---|---|---|
| Price | $ 56 | $ 87 | $ 136 |
| Change | -10.40% | 39.20% | 117.60% |
| Date | Upside/Downside | Analyst Firm | Price Target | Rating Change | Rating |
|---|---|---|---|---|---|
| 2026-03-18 | 60% | Mizuho | $84 → $100 | Maintains | Outperform |
| 2026-03-17 | 20% | JP Morgan | $74 → $75 | Maintains | Overweight |
| 2026-03-06 | 10.4% | UBS | $61 → $69 | Maintains | Neutral |
| 2026-02-26 | 34.4% | Leerink Partners | $83 → $84 | Maintains | Outperform |
| 2026-02-25 | 53.6% | Citizens | $88 → $96 | Maintains | Market Outperform |